Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-02 | Mr. Disbrow has been in the life sciences industry for over twenty-three years across pharmaceuticals, diagnostics, and medical devices. He has a Master of Business Administration from Wake Forest University and Bachelor of Science in Management from North Carolina State University. |
| 2021-04-02 | Josh co-founded Aytu BioPharma in 2015 and serves as the Aytu’s Chairman and Chief Executive Officer. He took the company public, having led Aytu’s listing on NASDAQ in 2017. |
| 2022-04-01 | Mr. Disbrow holds a Bachelor of Science in Management from North Carolina State University and a Master of Business Administration from Wake Forest University. |
| 2023-03-30 | Mr. Disbrow holds a Bachelor of Science in Management from North Carolina State University and a Master of Business Administration from Wake Forest University. |
| 2024-04-01 | Mr. Disbrow has been in the life sciences industry for over twenty-six years across pharmaceuticals, diagnostics, and medical devices. Mr. Disbrow co-founded Aytu BioPharma in 2015 and serves as the Aytu’s Chairman and Chief Executive Officer. |
| 2025-03-28 | Mr. Disbrow has been in the life sciences industry for twenty-eight years across pharmaceuticals, diagnostics, and medical devices. He holds a Bachelor of Science in Management from North Carolina State University and an MBA from Wake Forest University. |
Data sourced from SEC filings. Last updated: 2025-07-16